Guangdong Marubi Biotechnology Co.Ltd(603983)
Short form equity change report
Name of listed company: Guangdong Marubi Biotechnology Co.Ltd(603983) stock listing place: Shanghai Stock Exchange Stock abbreviation: Guangdong Marubi Biotechnology Co.Ltd(603983) Stock Code: Guangdong Marubi Biotechnology Co.Ltd(603983) information disclosure obligor: l capital Guangzhou beauty Ltd. company domicile: Suite 401, 4th floor, Ebene Esplanade, 24cybercity, Ebene, Mauritius Mailing address: Suite 401, 4th floor, Ebene Esplanade, 24cybercity, Ebene, Mauritius Nature of equity change: decrease in the number of shares and shareholding ratio
Date of signature: May 22, 2022
Statement of information disclosure obligor
1、 This report is prepared by the information disclosure obligor in accordance with the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies, the standards for the contents and forms of information disclosure by companies offering securities to the public No. 15 – Report on changes in equity and other relevant laws, regulations and normative documents.
2、 The information disclosure obligor has obtained necessary authorization and approval for signing this report, and its performance does not violate or conflict with any provision in the articles of association or internal rules of the information disclosure obligor.
3、 In accordance with the provisions of the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies, and the standards for the contents and forms of information disclosure by companies offering securities to the public No. 15 – Report on changes in equity, this report has fully disclosed the changes in shares in which the information disclosure obligor has interests in Guangdong Marubi Biotechnology Co.Ltd(603983) .
As of the signing date of this report, except for the information disclosed in this report, the information disclosure obligor has not increased or reduced its shares in Guangdong Marubi Biotechnology Co.Ltd(603983) .
4、 This equity change is based on the information stated in this report. The information disclosure obligor has not entrusted or authorized any other person to provide information not listed in this report and make any explanation or explanation to this report.
5、 There is no joint and several liability for the truthfulness, accuracy or misleading of the information recorded, omitted or disclosed in this report, and the individual is not jointly and severally liable.
catalogue
Section 1 interpretation Section 2 introduction of information disclosure obligors Section III purpose of equity change Section IV equity change method 8 section V Trading of listed shares within the first six months Section VI other major matters Section 7 documents for future reference Schedule 12 thirteen
Section I interpretation
In this report, unless the context otherwise requires, the following abbreviations have the following specific meanings:
Explanatory item refers to the explanatory content
Guangdong Marubi Biotechnology Co.Ltd(603983) simplified equity report refers to
Change report
This equity change l capital Guangzhou beauty Ltd. through the equity change of reducing its shareholding in Guangdong Wanmei Biotechnology Co., Ltd. disclosed in this report
Information disclosure obligor, l capital refers to l capital Guangzhou beauty Ltd
Guangdong Marubi Biotechnology Co.Ltd(603983) , listed company, company refers to Guangdong Marubi Biotechnology Co.Ltd(603983)
CSRC refers to the China Securities Regulatory Commission
Securities Law refers to the securities law of the people’s Republic of China
The acquisition Measures refer to the administrative measures for the acquisition of listed companies
The content and format of information disclosure of companies offering securities to the public refers to
Standard No. 15 – Report on changes in equity
Yuan and 10000 yuan refer to RMB yuan and 10000 yuan
There are differences in the mantissa between the sum of some totals and addends in this report. These differences are caused by rounding.
Section II introduction to information disclosure obligors
1、 Basic information of information disclosure obligor
Company name: l capital Guangzhou beauty Ltd
Company type: limited liability company
Registration No.: 115994 C1 / GBL
Date of establishment: April 29, 2013
Business term: no term
Registered capital USD 3676363937
Krishnacoomari bundhoo, director of the company
Helen Suzanne Gujadhur
Registered address: Suite 401, 4th floor, Ebene Esplanade, 24
Cybercity,Ebene,Mauritius.
Mailing address: Suite 401, 4th floor, Ebene Esplanade, 24
Cybercity,Ebene,Mauritius.
Business scope investment holding
Name and shareholding ratio of major shareholders l Capital Asia, L.L.C. holds 96.75%
2、 Information about the information disclosure obligors, directors and main principals
Other countries
Nationality or permanent residence
Krishnacoomari not applicable
Female Mauritius director bundhoo
Helen Suzanne not applicable
Female UK Mauritius director gujadhur
3、 Information disclosure obligor’s equity shares in other domestic and overseas listed companies reach or exceed 5% of the issued shares of the company
As of the signing date of this report, except for Guangdong Marubi Biotechnology Co.Ltd(603983) , the above information disclosure obligors do not hold shares with interests in other domestic and overseas listed companies that reach or exceed 5% of the issued shares of the company.
Section III purpose of equity change
1、 Purpose of this equity change
The purpose of this equity change is to meet the shareholders’ own capital needs.
L Capital Asia, LLC is a professional private equity investment institution. L capital Guangzhou beauty Ltd. is the main body established by L Capital Asia, LLC to invest in Guangdong Marubi Biotechnology Co.Ltd(603983) and took shares in Guangdong Marubi Biotechnology Co.Ltd(603983) in May 2013. It has been nine years since then. During this period, l capital Guangzhou beauty Ltd. has established a friendly and mutual trust cooperative relationship and has always been optimistic about the development and future of Guangdong Marubi Biotechnology Co.Ltd(603983) . Since l capital has held Guangdong Marubi Biotechnology Co.Ltd(603983) shares for a long time, as an equity investment company, it has its own capital withdrawal needs.
2、 Shareholding plan of information disclosure obligor in the next 12 months
As of the signing date of this report, the information disclosure obligor will further dispose of its equity shares in the listed company according to its actual situation in the next 12 months. In case of relevant equity changes, the information disclosure obligor will perform the information disclosure obligations in strict accordance with relevant laws and regulations.
Section IV changes in equity
1、 Shares held by information disclosure obligors
Before this equity change, l capital, the information disclosure obligor, held 26999194 shares of the company, accounting for about 671923% of the total share capital of the company. After this equity change, the information disclosure obligor holds 20090880 shares of the company, accounting for about 499998% of the total share capital of the company. After this reduction, l capital is no longer a shareholder of Guangdong Marubi Biotechnology Co.Ltd(603983) holding more than 5%.
2、 Main changes in equity of information disclosure obligor this time
1. Share reduction of L capital:
Number and proportion of shareholders’ reduction during the period of reduction, reduction price, total amount of reduction name (shares) mode range (yuan / amount (10000 yuan) shares)
L capital 6908314171926% 2022 / 5 / 20 block trading 19.391339522
2. Before and after the completion of this change, the shares and interests of the listed company held by the information disclosure obligor are as follows:
Shares held before changes in shareholders’ equity shares held after changes in shareholders’ equity
Name nature number of shares (shares) in total share capital proportion of shares (shares) in total share capital
Unlimited sale
Lcapital conditional flow 26999194671923% 20090880499998%
Through stock
3、 Impact of this transfer on Listed Companies
This equity change will not lead to changes in the controlling shareholders and actual controllers of the company, nor will it damage the rights and interests of the company and other shareholders, nor will it affect the normal production and operation of the company.
4、 Restrictions on share rights of listed companies involved in this equity change
The shares of Guangdong Marubi Biotechnology Co.Ltd(603983) held by the information disclosure obligor have no right restrictions, including but not limited to the pledge and freezing of shares.
Section V Trading of listed shares in the first six months
The information disclosure obligor has not bought or sold Guangdong Marubi Biotechnology Co.Ltd(603983) shares within 6 months before the signing date of this report.
Section VI other major matters
As of the signing date of this report, the information disclosure obligor has truthfully disclosed the relevant information of this equity change in accordance with relevant regulations, and there is no other major information that should be disclosed in order to avoid misunderstanding of the content of this report.
Statement of information disclosure obligor
I (and the organization I represent) promise that there are no false records, misleading statements or major omissions in this report, and bear individual and joint legal liabilities for its authenticity, accuracy and completeness.
Information disclosure obligor: l capital Guangzhou beauty Ltd. director: krishnacoomali bundhoo May 22, 2022
